Medtronic is working on an update to fix a missing encryption of sensitive data issue in its N’Vision Clinician Programmer, according to a report with NCCIC.
As part of the normal functionality of this device, the N’Vision Clinician Programmer may store Personal Health Information (PHI) or Personal Identifying Information (PII).
Successful exploitation of this vulnerability, discovered by Billy Rios of Whitescope LLC, may allow an attacker with physical access to an 8870 N’Vision Compact Flash card to access this PHI or PII.
The N’Vision Clinician Programmer is a small, portable device that offers a single programming platform for Medtronic Neurological implantable therapy devices.
The following products suffer from the issue:
• 8840 N’Vision Clinician Programmer, all versions
• 8870 N’Vision removable Application Card, all versions
The affected product does not encrypt the following sensitive information while at rest:
PII – Personally Identifiable Information. Some combination of personal data that enables the unique identification of an individual. PII is defined as “information that can be used to distinguish or trace an individual’s identity, either alone or when combined with other personal or identifying information that is linked or linkable to a specific individual.”
PHI – Protected Health Information. Some combination of PII and associated health related data.
CVE-2018-8849 is the case number assigned to this vulnerability, which has a CVSS v3 base score of 4.6.
The product sees use mainly in the healthcare and public health sectors. It also sees action on a global basis.
No known public exploits specifically target this vulnerability. This vulnerability is not exploitable remotely. However, an attacker with low skill level could leverage the vulnerability.
Medtronic has not developed a product update to address the vulnerability, but is reinforcing security reminders within this advisory to help reduce the risk associated with the vulnerability
The 8870 Therapy Application card stores PHI and PII as part of its normal operating procedure and should be handled, managed and secured in a manner consistent with the applicable laws for patient data privacy.
Dublin, Ireland-based Medtronic recommends users take additional defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, hospitals and clinicians should:
• Maintain strict physical control of the 8870 application card.
• Use only legitimately obtained 8870 cards and not cards provided by any third party as firmware and system updates are provided directly by Medtronic using new 8870 application cards.
• 8840 Programmers and 8870 Therapy Application compact flash cards are the property of Medtronic and should be returned to Medtronic when no longer in use. If that is not an option, you should securely dispose of them.
Medtronic released additional patient focused information.